Precision medicine in breast cancer: From clinical trials to clinical practice
Author:
Funder
Boehringer Ingelheim
GlaxoSmithKline
Daiichi-Sankyo
Merck
Ministero della Salute
Genentech
Samsung
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference126 articles.
1. Precision oncology: An overview;Garraway;J Clin Oncol,2013
2. A framework to rank genomic alterations as targets for cancer precision medicine: The ESMO Scale for Clinical Actionability of molecular Targets (ESCAT);Mateo;Ann Oncol,2018
3. Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT);Condorelli;Ann Oncol,2019
4. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
5. Breast Cancer Treatment: A Review;Waks;JAMA - J Am Med Assoc,2019
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2;Pathology - Research and Practice;2024-10
2. Minimally Invasive, Maximally Effective;Surgical Pathology Clinics;2024-09
3. Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers;Frontiers in Immunology;2024-05-29
4. HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity;Cancers;2024-05-25
5. Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer;npj Breast Cancer;2024-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3